STC1 and breast cancer: Mccudden et al58 showed that STC1 and its receptor were colocalized in 91% of examined human breast cancer biopsies (53/58) by immunocytochemistry and in situ ligand and binding staining, and all cancerous cells were positively stained for both the ligand and receptor.